MAKERS LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 129 INR | -1.60% |
|
-6.83% | -6.93% |
| 05-23 | Makers Laboratories Gets Board Nod to Sell Mumbai, India Property to Ipca Laboratories | MT |
| 05-23 | Makers Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 359.9 | 258.9 | 146.5 | 1,176 | 897.8 | 576.2 |
| Enterprise Value (EV) 1 | 361.2 | 301.1 | 268.3 | 1,282 | 1,010 | 671 |
| P/E ratio | 11.8 x | 10.6 x | -118 x | -357 x | 18 x | -12.4 x |
| Yield | 1.37% | 1.9% | - | - | - | - |
| Capitalization / Revenue | 0.64 x | 0.56 x | 0.29 x | 1.71 x | 0.7 x | 0.57 x |
| EV / Revenue | 0.65 x | 0.65 x | 0.52 x | 1.87 x | 0.79 x | 0.66 x |
| EV / EBITDA | 6.14 x | 6.71 x | 9.35 x | 23.7 x | 5.06 x | 19.6 x |
| EV / FCF | -11.8 x | -9.31 x | -5.22 x | - | -42.3 x | -5.22 x |
| FCF Yield | -8.46% | -10.7% | -19.1% | - | -2.36% | -19.1% |
| Price to Book | 0.98 x | 0.62 x | 0.33 x | 2.17 x | 1.51 x | 0.83 x |
| Nbr of stocks (in thousands) | 4,917 | 4,917 | 4,917 | 4,917 | 4,917 | 5,900 |
| Reference price 2 | 73.20 | 52.65 | 29.80 | 239.2 | 182.6 | 97.65 |
| Announcement Date | 18-07-05 | 19-07-08 | 20-08-11 | 21-07-16 | 22-07-15 | 23-07-07 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 559 | 466.2 | 514 | 686.4 | 1,284 | 1,013 |
| EBITDA 1 | 58.82 | 44.9 | 28.68 | 54.1 | 199.5 | 34.2 |
| EBIT 1 | 43.22 | 29.89 | 11.37 | 36.79 | 162.1 | -5.379 |
| Operating Margin | 7.73% | 6.41% | 2.21% | 5.36% | 12.62% | -0.53% |
| Earnings before Tax (EBT) 1 | 42.36 | 30.16 | 2.49 | 27.05 | 156.9 | -8.385 |
| Net income 1 | 30.57 | 24.49 | -1.238 | -3.292 | 49.78 | -47.51 |
| Net margin | 5.47% | 5.25% | -0.24% | -0.48% | 3.88% | -4.69% |
| EPS 2 | 6.217 | 4.980 | -0.2518 | -0.6695 | 10.12 | -7.900 |
| Free Cash Flow 1 | -30.57 | -32.36 | -51.38 | - | -23.88 | -128.5 |
| FCF margin | -5.47% | -6.94% | -10% | - | -1.86% | -12.69% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | 1.000 | 1.000 | - | - | - | - |
| Announcement Date | 18-07-05 | 19-07-08 | 20-08-11 | 21-07-16 | 22-07-15 | 23-07-07 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1.27 | 42.2 | 122 | 106 | 112 | 94.8 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.0215 x | 0.9408 x | 4.246 x | 1.953 x | 0.5633 x | 2.773 x |
| Free Cash Flow 1 | -30.6 | -32.4 | -51.4 | - | -23.9 | -128 |
| ROE (net income / shareholders' equity) | 8.62% | 6.24% | -0.29% | 2.06% | 12.7% | -2.11% |
| ROA (Net income/ Total Assets) | 5.22% | 3.3% | 1.06% | 2.19% | 7.22% | -0.23% |
| Assets 1 | 585.7 | 742.6 | -116.6 | -150.4 | 689.2 | 20,966 |
| Book Value Per Share 2 | 74.90 | 84.80 | 90.70 | 110.0 | 121.0 | 117.0 |
| Cash Flow per Share 2 | 0.3300 | 4.390 | 1.760 | 10.70 | 4.690 | 1.220 |
| Capex 1 | 21 | 89.2 | 85.9 | - | 98.9 | 129 |
| Capex / Sales | 3.75% | 19.14% | 16.71% | - | 7.7% | 12.74% |
| Announcement Date | 18-07-05 | 19-07-08 | 20-08-11 | 21-07-16 | 22-07-15 | 23-07-07 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -6.93% | 9.27M | |
| +20.76% | 43.59B | |
| +28.00% | 22.54B | |
| +20.14% | 15.73B | |
| +18.82% | 14.33B | |
| +55.83% | 12.75B | |
| -0.05% | 6.79B | |
| -12.70% | 6.48B | |
| -8.87% | 5.73B | |
| +15.72% | 5.67B |
- Stock Market
- Equities
- MAKERSL6 Stock
- Financials Makers Laboratories Limited
